Royalty Pharma plc revenue breakdown overview

Royalty Pharma plc revenue for the last year amounted to 3.05 B USD, the most of which — 2.35 B USD — came from its highest performing source at the moment, Biopharmaceutical Royalties, the year earlier bringing 2.24 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Royalty Pharma plc 2.35 B USD, and the year before that — 2.24 B USD.